Bhubaneswar: The Drugs Controller General of India (DCGI) on Thursday granted conditional market approval for COVID-19 vaccines, Covishield and Covaxin, for use in adult population with certain conditions.
The vaccines, however, will not be available at medical stores. Hospitals and clinics can purchase the vaccines.
The approval has been granted under the New Drugs and Clinical Trials Rules, 2019.
The price of these vaccines of Serum Institute of India and Bharat Biotech is likely to be capped at Rs 275 per dose plus an additional service charge of Rs 150, the PTI reported quoting official sources.
Both the vaccines are currently only authorised for emergency use in India. While Covaxin is priced at Rs 1,200 per dose, Covishield costs Rs 780 at private facilities.
Bhubaneswar: The Odisha government on Saturday announced that another phase of money in first instalment… Read More
Mumbai: Sonakshi Sinha, daughter of actor Shatrughan and Poonam Sinha, has revealed that her elder… Read More
Paradip: A labourer was killed in a mishap during construction work at the refinery of… Read More
New Delhi: The holy month of Ramadan, or Ramzan, will start on Sunday in India.… Read More
Mumbai: The 82-year-old Amitabh Bachchan, a superstar in his league, took to social media to… Read More
Bargarh: A robbery attempt was foiled at the main branch of the State Bank of… Read More
This website uses cookies.
